Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

BACKGROUND: The importance of 2-yr postradiotherapy prostate biopsy status remains uncertain. OBJECTIVE: To assess the value of 2 year post treatment biopsies in a randomised trial of radiotherapy dose escalation. DESIGN, SETTING, AND PARTICIPANTS: Between 1998 and 2001, 843 men with localised prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Kass-Iliyya, Antoine, Jovic, Gordana, Murphy, Claire, Fisher, Cyril, Syndikus, Isabel, Jose, Chakiath, Scrase, Christopher D., Graham, John D., Nicol, David, Sydes, Matthew R., Dearnaley, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954168/
https://www.ncbi.nlm.nih.gov/pubmed/29307509
http://dx.doi.org/10.1016/j.eururo.2017.12.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954168/
https://www.ncbi.nlm.nih.gov/pubmed/29307509
http://dx.doi.org/10.1016/j.eururo.2017.12.017

Ejemplares similares